Doctors

New research is shedding light on notable differences in the clinicopathological characteristics and long-term prognosis of patients with IgA nephropathy (IgAN) and nephrotic syndrome (NS) across different pathological phenotypes.1 Study findings suggest differences in the clinical features and renal prognosis of patients with IgAN-NS and minimal change disease (MCD), membranous nephropathy (MN), membranoproliferative glomerulonephritis (IgAN-MPGN), … Read more

Abebaw Yohannes, MSc, PhDCredit: American Lung Association Prevalence of depression: Chronic obstructive pulmonary disease (COPD) is a major cause of disability, morbidity, and premature mortality.1,2 Approximately, two-thirds of COPD patients live with 2 or more comorbidities.4,5 Of these, over 40% suffer from co-morbid depression that warrants medical intervention; however, many remain undiagnosed and thus untreated.6 … Read more

Donghee Kim, MD, PhD Credit: Stanford Medicine New research is providing insight into the prevalence of lean steatotic liver disease (SLD) in the US, addressing potential changes in previous estimates following a 2023 change in liver disease nomenclature.1 Leveraging National Health and Nutrition Examination Survey (NHANES) data from 2017-2023, investigators determined the age-adjusted prevalence of … Read more

Cara L. McDermott, PharmD, PhD Credit: Cancer and Aging Research Group New research has found a large proportion of injurious falls, which were made more likely with high fall-risk increasing drug (FRID) burden, in adults with chronic obstructive pulmonary disease (COPD) near end of life.1 “Fall-risk increasing drugs are commonly prescribed to people with COPD … Read more

Chia-Chih Kuo, APN Credit: ResearchGate Treatment with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) is associated with better long-term liver outcomes than sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes (T2D), according to findings from a recent study.1 Leveraging data for more than 150,000 patients from the … Read more

New research has yielded an updated definition of hyperfiltration to address age-related renal function decline in kidney donor candidates with obesity and glucose tolerance disorder.1 The revised formula uses both age and glomerular filtration rate (GFR) without body surface area correction to determine the threshold value for hyperfiltration, overcoming inherent limitations of the conventional method … Read more